DK165620C - Frysetoerret farmaceutisk praeparat indeholdende anthracyclinglycosider og et cosolubiliserende middel og fremgangsmaade til fremstilling heraf, anvendelse af praeparatet til fremstilling af et tumormiddel samt fremgangsmaade til fremstilling af en rekonstitueret injicerbar oploesning af praeparatet - Google Patents

Frysetoerret farmaceutisk praeparat indeholdende anthracyclinglycosider og et cosolubiliserende middel og fremgangsmaade til fremstilling heraf, anvendelse af praeparatet til fremstilling af et tumormiddel samt fremgangsmaade til fremstilling af en rekonstitueret injicerbar oploesning af praeparatet

Info

Publication number: DK165620C
Authority: DK; Denmark
Prior art keywords: preparation; anthracycliclycoside; annostation; cosolubilizing; freeze
Prior art date: 1984-10-22

Application number

DK481585A

Other languages

Danish (da)

English (en)

Other versions

DK481585A (da

DK165620B (da

DK481585D0 (da

Inventor

Gaetano Gatti

Diego Oldani

Carlo Confalonieri

Luciano Gambini

Original Assignee

Erba Carlo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-10-22

Filing date

1985-10-21

Publication date

1993-06-01

1985-10-21 Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa

1985-10-21 Publication of DK481585D0 publication Critical patent/DK481585D0/da

1986-04-23 Publication of DK481585A publication Critical patent/DK481585A/da

1992-12-28 Publication of DK165620B publication Critical patent/DK165620B/da

1993-06-01 Application granted granted Critical

1993-06-01 Publication of DK165620C publication Critical patent/DK165620C/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK481585A 1984-10-22 1985-10-21 Frysetoerret farmaceutisk praeparat indeholdende anthracyclinglycosider og et cosolubiliserende middel og fremgangsmaade til fremstilling heraf, anvendelse af praeparatet til fremstilling af et tumormiddel samt fremgangsmaade til fremstilling af en rekonstitueret injicerbar oploesning af praeparatet DK165620C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8426672		1984-10-22
GB848426672A GB8426672D0 (en)	1984-10-22	1984-10-22	Pharmaceutical compositions

Publications (4)

Publication Number	Publication Date
DK481585D0 DK481585D0 (da)	1985-10-21
DK481585A DK481585A (da)	1986-04-23
DK165620B DK165620B (da)	1992-12-28
DK165620C true DK165620C (da)	1993-06-01

Family

ID=10568553

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK481585A DK165620C (da)	1984-10-22	1985-10-21	Frysetoerret farmaceutisk praeparat indeholdende anthracyclinglycosider og et cosolubiliserende middel og fremgangsmaade til fremstilling heraf, anvendelse af praeparatet til fremstilling af et tumormiddel samt fremgangsmaade til fremstilling af en rekonstitueret injicerbar oploesning af praeparatet

Country Status (35)

Country	Link
US (4)	US4675311A (es)
JP (1)	JPH0611700B2 (es)
KR (1)	KR920005813B1 (es)
CN (1)	CN85107562B (es)
AT (1)	AT401345B (es)
AU (1)	AU572003B2 (es)
BE (1)	BE903484A (es)
BG (1)	BG60934B2 (es)
CA (1)	CA1248453A (es)
CH (1)	CH667594A5 (es)
CS (1)	CS270421B2 (es)
DE (1)	DE3536896C2 (es)
DK (1)	DK165620C (es)
ES (1)	ES8605374A1 (es)
FI (2)	FI853913A (es)
FR (1)	FR2571966B1 (es)
GB (2)	GB8426672D0 (es)
GR (1)	GR852549B (es)
HK (1)	HK94390A (es)
HU (1)	HU197988B (es)
IE (1)	IE56992B1 (es)
IL (1)	IL76732A (es)
IT (1)	IT1186779B (es)
MY (1)	MY103956A (es)
NL (1)	NL191308C (es)
NO (1)	NO170616C (es)
NZ (1)	NZ213885A (es)
PH (1)	PH23982A (es)
PT (1)	PT81347B (es)
RU (2)	RU1836088C (es)
SE (1)	SE467520B (es)
SG (1)	SG80290G (es)
UA (2)	UA19169A (es)
YU (1)	YU46160B (es)
ZA (1)	ZA858033B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5124318A (en) *	1985-08-02	1992-06-23	Farmitalia Carlo Erba S.R.L.	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5977082A (en) *	1985-08-02	1999-11-02	Pharmacia & Upjohn Company	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) *	1985-08-02	1992-06-23	Farmitalia Carlo Erba S.P.A.	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
FI91710C (fi) *	1986-12-05	1994-08-10	Erba Carlo Spa	Menetelmä injektoitavan käyttövalmiin, säilytystä kestävän, steriilin antrasykliiniglykosidiliuoksen valmistamiseksi
JP2603480B2 (ja) *	1987-08-05	1997-04-23	住友製薬株式会社	安定化されたアンスラサイクリン系製剤
DE3801178A1 (de) *	1988-01-18	1989-07-27	Hoechst Ag	Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
US6300362B1 (en)	1990-07-25	2001-10-09	Novartis Ag (Formerly Sandoz Ltd.)	Stabilized pharmaceutical compositions comprising acid donors
CA2628857C (en)	1996-12-30	2011-09-13	Batelle Memorial Institute	Formulation and method for treating neoplasms by inhalation
US5942508A (en) *	1997-02-04	1999-08-24	Senju Pharmaceutical Co., Ltd.	Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
BRPI0307802B8 (pt)	2002-02-22	2021-05-25	Merck Sharp & Dohme	formulação farmacêutica compreendendo temozolomida, processo para a produção da mesma, bem como artigo fabricado contendo pó liofilizado compreendendo temozolomida
DK1474995T3 (da) *	2003-05-06	2013-02-18	Gumlink As	Fremgangsmåde til fremstilling af tyggegummigranulater, et gummisammensætningsekstruder- og granuleringssystem og et tyggegummiprodukt
US20090099346A1 (en) *	2003-07-02	2009-04-16	Victor Matvienko	Thermally stable crystalline epirubicin hydrochloride
RU2341530C2 (ru) *	2003-07-02	2008-12-20	Солакс Корпорейшн	Термостойкий кристаллический гидрохлорид эпирубицина и способ его получения
ATE471740T1 (de) *	2003-09-25	2010-07-15	Astellas Pharma Inc	Antitumorales mittel mit einem histon-deacetylase-hemmer und einem topoisomerase-ii-hemmer
US7388083B2 (en) *	2005-03-07	2008-06-17	Solux Corporation	Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
WO2006122309A2 (en) *	2005-05-11	2006-11-16	Sicor, Inc.	Stable lyophilized anthracycline glycosides
AU2006270165B2 (en)	2005-07-14	2010-03-11	Neothetics, Inc.	Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
EP1976858B1 (en) *	2005-12-13	2016-01-06	Solux Corporation	Method for preparing 4-demethyldaunorubicin
US8802830B2 (en) *	2005-12-20	2014-08-12	Solux Corporation	Synthesis of epirubicin from 13-dihydrodaunorubicine
US8148338B2 (en) *	2006-02-22	2012-04-03	Supratek Pharma Inc.	Doxorubicin formulations for anti-cancer use
US7470672B2 (en) *	2006-07-31	2008-12-30	Savvipharm Inc.	Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
KR20100029764A (ko) *	2007-05-16	2010-03-17	케이티비 투머포슝스케쉘샤프트 엠비에이치	저점성 안트라사이클린 제제
ES2439497T3 (es)	2007-09-04	2014-01-23	Meiji Seika Pharma Co., Ltd.	Preparación de una inyección, de una solución para inyección y de un kit de inyección
CA2703149A1 (en) *	2007-10-26	2009-04-30	Pfizer Products Inc.	Idarubicin for the treatment of lymphoma in a dog
US8357785B2 (en) *	2008-01-08	2013-01-22	Solux Corporation	Method of aralkylation of 4′-hydroxyl group of anthracylins
US9132084B2 (en)	2009-05-27	2015-09-15	Neothetics, Inc.	Methods for administration and formulations for the treatment of regional adipose tissue
SG182485A1 (en) *	2010-01-15	2012-08-30	Lithera Inc	Lyophilized cake formulations
AU2011336869B2 (en)	2010-11-24	2016-09-15	Neothetics, Inc.	Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
DE102011103751A1 (de)	2011-05-31	2012-12-06	Heraeus Precious Metals Gmbh & Co. Kg	Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) *	2011-08-30	2013-02-28	Lead Discovery Center Gmbh	Neue Cyclosporin-Derivate
DK2931042T3 (da)	2012-12-13	2021-06-07	Cytrx Corp	Anthracyclinformuleringer
EP3003489B1 (en)	2013-06-05	2021-08-18	CytRx Corporation	Cytotoxic agents for the treatment of cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU33730B (en) *	1967-04-18	1978-02-28	Farmaceutici Italia	Process for preparing a novel antibiotic substance and salts thereof
US4039663A (en) *	1975-03-19	1977-08-02	Societa' Farmaceutici Italia S.P.A.	Daunomycins, process for their uses and intermediates
GB1506200A (en) *	1975-04-30	1978-04-05	Farmaceutici Italia	Glycosides
GB1567456A (en) *	1976-11-16	1980-05-14	Farmaceutici Italia	Daunomycin derivatives
US4177264A (en) *	1977-10-17	1979-12-04	Sri International	N-benzyl anthracyclines
GB2007645B (en) *	1977-10-17	1982-05-12	Stanford Res Inst Int	Benzyl anthracyclines and pharmaceutical compositions containing them
JPS563851A (en) *	1979-06-22	1981-01-16	Matsushita Electric Works Ltd	Fireplace in floor
JPS5756494A (en) *	1980-09-22	1982-04-05	Microbial Chem Res Found	New anthracyclin derivative
US4325947A (en) *	1981-05-12	1982-04-20	Farmitalia Carlo Erba S.P.A.	4-Demethoxy-4'-deoxydoxorubicin
IT1210476B (it) *	1981-05-28	1989-09-14	Erba Farmitalia	Antracicline.
US4438105A (en) *	1982-04-19	1984-03-20	Farmaitalia Carlo Erba S.P.A	4'-Iododerivatives of anthracycline glycosides
DE3317702A1 (de) *	1982-05-24	1983-11-24	Farmitalia Carlo Erba S.p.A., 20159 Milano	Anthracyclinglykoside, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
US4464529A (en) *	1982-07-20	1984-08-07	Sri International	Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
CA1248944A (en) *	1982-09-28	1989-01-17	Gareth J. Thomas	Anthracycline glycosides
JPS5982395A (ja) *	1982-11-02	1984-05-12	Microbial Chem Res Found	アントラサイクリン化合物、その製造法およびその用途
GR79729B (es) *	1982-12-20	1984-10-31	Univ Ohio State Res Found
JPS6092212A (ja) *	1983-10-26	1985-05-23	Kyowa Hakko Kogyo Co Ltd	ドキソルビシン塩の製剤
US4537882A (en) *	1984-05-10	1985-08-27	Ohio State University	4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same

1984
- 1984-10-22 GB GB848426672A patent/GB8426672D0/en active Pending
1985
- 1985-10-03 ES ES547578A patent/ES8605374A1/es not_active Expired
- 1985-10-08 FI FI853913A patent/FI853913A/fi not_active Application Discontinuation
- 1985-10-15 CN CN85107562A patent/CN85107562B/zh not_active Expired
- 1985-10-15 HU HU853988A patent/HU197988B/hu unknown
- 1985-10-16 DE DE3536896A patent/DE3536896C2/de not_active Expired - Lifetime
- 1985-10-16 YU YU164485A patent/YU46160B/sh unknown
- 1985-10-16 IT IT22507/85A patent/IT1186779B/it active Protection Beyond IP Right Term
- 1985-10-16 US US06/788,158 patent/US4675311A/en not_active Expired - Lifetime
- 1985-10-16 FI FI854035A patent/FI86252C/fi not_active IP Right Cessation
- 1985-10-17 CH CH4476/85A patent/CH667594A5/de not_active IP Right Cessation
- 1985-10-17 AU AU48805/85A patent/AU572003B2/en not_active Expired
- 1985-10-17 IL IL76732A patent/IL76732A/xx not_active IP Right Cessation
- 1985-10-17 JP JP60230055A patent/JPH0611700B2/ja not_active Expired - Lifetime
- 1985-10-18 ZA ZA858033A patent/ZA858033B/xx unknown
- 1985-10-18 RU SU853964940A patent/RU1836088C/ru active
- 1985-10-18 GB GB08525709A patent/GB2165751B/en not_active Expired
- 1985-10-18 PH PH32947A patent/PH23982A/en unknown
- 1985-10-18 AT AT0303285A patent/AT401345B/de not_active IP Right Cessation
- 1985-10-18 UA UA3964940A patent/UA19169A/uk unknown
- 1985-10-18 UA UA5010680A patent/UA34419C2/uk unknown
- 1985-10-18 NZ NZ213885A patent/NZ213885A/en unknown
- 1985-10-21 DK DK481585A patent/DK165620C/da not_active IP Right Cessation
- 1985-10-21 SE SE8504945A patent/SE467520B/sv not_active IP Right Cessation
- 1985-10-21 KR KR1019850007740A patent/KR920005813B1/ko not_active IP Right Cessation
- 1985-10-21 PT PT81347A patent/PT81347B/pt unknown
- 1985-10-21 IE IE2593/85A patent/IE56992B1/en not_active IP Right Cessation
- 1985-10-21 NO NO854194A patent/NO170616C/no not_active IP Right Cessation
- 1985-10-21 FR FR8515596A patent/FR2571966B1/fr not_active Expired
- 1985-10-21 BE BE0/215752A patent/BE903484A/fr not_active IP Right Cessation
- 1985-10-21 CA CA000493459A patent/CA1248453A/en not_active Expired
- 1985-10-21 NL NL8502869A patent/NL191308C/xx not_active IP Right Cessation
- 1985-10-22 CS CS857565A patent/CS270421B2/cs not_active IP Right Cessation
- 1985-10-22 GR GR852549A patent/GR852549B/el unknown
1986
- 1986-08-06 US US06/893,613 patent/US4840938A/en not_active Expired - Lifetime
1988
- 1988-12-30 MY MYPI88001588A patent/MY103956A/en unknown
1990
- 1990-09-26 US US07/588,526 patent/US5091372A/en not_active Expired - Lifetime
- 1990-09-28 US US07/590,536 patent/US5091373A/en not_active Expired - Lifetime
- 1990-10-03 SG SG802/90A patent/SG80290G/en unknown
- 1990-11-15 HK HK943/90A patent/HK94390A/xx not_active IP Right Cessation
1992
- 1992-01-30 RU SU5010680A patent/RU2101018C1/ru active
1994
- 1994-02-23 BG BG098530A patent/BG60934B2/bg unknown

Also Published As

Publication number	Publication date
AT401345B (de)	1996-08-26
ES8605374A1 (es)	1986-03-16
HU197988B (en)	1989-07-28
FR2571966A1 (fr)	1986-04-25
IE852593L (en)	1986-04-22
CS270421B2 (en)	1990-06-13
DK481585A (da)	1986-04-23
KR920005813B1 (ko)	1992-07-20
US4675311A (en)	1987-06-23
DE3536896C2 (de)	1996-11-14
CN85107562B (zh)	1988-06-01
IT1186779B (it)	1987-12-16
BG60934B2 (bg)	1996-06-28
SE8504945D0 (sv)	1985-10-21
NO854194L (no)	1986-04-23
YU164485A (en)	1987-10-31
PH23982A (en)	1990-02-09
UA19169A (uk)	1997-12-25
KR860003014A (ko)	1986-05-19
RU1836088C (ru)	1993-08-23
FI854035A0 (fi)	1985-10-16
RU2101018C1 (ru)	1998-01-10
IT8522507A0 (it)	1985-10-16
BE903484A (fr)	1986-04-21
ES547578A0 (es)	1986-03-16
CN85107562A (zh)	1986-07-23
AU572003B2 (en)	1988-04-28
NO170616B (no)	1992-08-03
NL191308C (nl)	1995-05-16
IL76732A (en)	1989-07-31
PT81347A (en)	1985-11-01
GB2165751A (en)	1986-04-23
US5091372A (en)	1992-02-25
HK94390A (en)	1990-11-23
DE3536896A1 (de)	1986-04-24
DK165620B (da)	1992-12-28
FI86252B (fi)	1992-04-30
SG80290G (en)	1990-11-23
PT81347B (pt)	1987-11-11
CH667594A5 (de)	1988-10-31
FI853913A0 (fi)	1985-10-08
UA34419C2 (uk)	2001-03-15
FI854035L (fi)	1986-04-23
YU46160B (sh)	1993-05-28
GR852549B (es)	1986-02-24
SE467520B (sv)	1992-08-03
GB2165751B (en)	1988-08-17
GB8426672D0 (en)	1984-11-28
NO170616C (no)	1992-11-11
JPH0611700B2 (ja)	1994-02-16
IL76732A0 (en)	1986-02-28
FR2571966B1 (fr)	1988-04-15
GB8525709D0 (en)	1985-11-20
NL191308B (nl)	1994-12-16
FI853913A (fi)	1986-04-23
ATA303285A (de)	1996-01-15
DK481585D0 (da)	1985-10-21
MY103956A (en)	1993-10-30
IE56992B1 (en)	1992-02-26
AU4880585A (en)	1986-05-01
ZA858033B (en)	1986-06-25
JPS61246129A (ja)	1986-11-01
FI86252C (fi)	1992-08-10
US5091373A (en)	1992-02-25
CS756585A2 (en)	1989-11-14
HUT40759A (en)	1987-02-27
NL8502869A (nl)	1986-05-16
NZ213885A (en)	1988-05-30
CA1248453A (en)	1989-01-10
SE8504945L (sv)	1986-04-23
US4840938A (en)	1989-06-20

Publication	Publication Date	Title
DK165620C (da)	1993-06-01	Frysetoerret farmaceutisk praeparat indeholdende anthracyclinglycosider og et cosolubiliserende middel og fremgangsmaade til fremstilling heraf, anvendelse af praeparatet til fremstilling af et tumormiddel samt fremgangsmaade til fremstilling af en rekonstitueret injicerbar oploesning af praeparatet
NO821486L (no)	1982-11-08	Tubeformet beholder og fremgangsmaate til dennes fremstilling
NO163230C (no)	1992-02-25	Fenol-, formaldehyd- og ureksondensat samt fremstilling og anvendelse derav.
MX9845A (es)	1993-12-01	Propanaminas 3-ariloxi-3-substituidas y procedimiento para su preparacion.
DK477686A (da)	1987-04-09	Heteropolysaccharid, fremgangsmaade til fremstilling deraf og anvendelse deraf i et kompleks samt fremgangsmaade til fremstilling af et saadant kompleks
DK215986D0 (da)	1986-05-09	Fremgangsmaade til fremstilling af slikstaenger, der indeholder vaffel ogcreme, og vaffelstaenger fremstillet derved
DK418985D0 (da)	1985-09-16	Indkapslede pyrethroider samt fremgangsmaade til fremstilling deraf oganvendelse som insecticid
DK328083D0 (da)	1983-07-15	Opvaskemiddel samt fremgangsmade til fremstilling deraf
DK70385D0 (da)	1985-02-15	Bakteriepraeparat og fremgangsmaade til fremstilling deraf
NO871547D0 (no)	1987-04-13	Hurtigkobling for roer og lignende.
NO163962C (no)	1990-08-15	Flytende vaskemiddel og fremgangsmaate for fremstilling avdette.
DK159637C (da)	1991-04-22	Sukkerfrie bolsjer og fremgangsmaade til deres fremstilling
DK327783A (da)	1984-01-18	Instant-drikke og instant-te samt fremgangsmaade til fremstilling heraf
DK261086D0 (da)	1986-06-03	Katalysator til katalytisk krakning og fremgangsmaade til fremstilling af samme samt anvendelse heraf
DK497682A (da)	1983-05-10	Fremgangsmaade til fremstilling af 7-oxabicycloheptan- og 7-oxabicycloheptenprostaglandinanaloge
DK446982A (da)	1983-04-10	Cyanosteroider og fremgangsmaade til deres fremstilling
DK493082A (da)	1983-05-07	Acylanilider og fremgangsmaader til fremstilling heraf
DK95590D0 (da)	1990-04-18	Fremgangsmaade til at demodulere dataer
NO855026L (no)	1986-06-16	Aminoacyllabdaner og fremgangsmaate til fremstilling derav.
DK382785D0 (da)	1985-08-23	Alfa-(o-chlorphenyl)-aminomethylen-beta-formylaminopropionitril, fremgangsmaade til fremstilling af dette samt anvendelse af dette til fremstilling af 2-methyl-4-amino-5-formylaminomethyl-pyrimidin
DK158522C (da)	1990-11-05	Beta-amylase, samt fremstilling og anvendelse deraf
DK60982A (da)	1982-08-13	Oxalkylerede naphthol-novolaker,fremgangsmaade til deres fremstilling og deres anvendelse
DK48482A (da)	1982-08-08	Azopigmentpraeparater,fremgangsmaade til deres fremstilling og deres anvendelse
DK156480A (da)	1980-10-14	Hoejaktiv soelvkatode og fremgangsmaade til fremstilling deraf samt katodens anvendelse til fremstilling af 2,3,5-trichlorpyridin
DK163285D0 (da)	1985-04-11	4-hydroxy-2h-1-benzothiopyran-2-on-forbindelser og fremgangsmaade til fremstilling deraf samt rodenticidt middel

Legal Events

Date	Code	Title	Description
2005-11-07	PUP	Patent expired